Aldeyra Therapeutics Files 8-K Report
Ticker: ALDX · Form: 8-K · Filed: Jul 17, 2025 · CIK: 1341235
| Field | Detail |
|---|---|
| Company | Aldeyra Therapeutics, INC. (ALDX) |
| Form Type | 8-K |
| Filed Date | Jul 17, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, pharmaceutical
TL;DR
Aldeyra Therapeutics filed an 8-K on 7/17/25. Standard corporate update.
AI Summary
On July 17, 2025, Aldeyra Therapeutics, Inc. filed an 8-K report. The filing indicates that the company is a pharmaceutical preparations company incorporated in Delaware with its principal executive offices located in Lexington, MA. The report does not contain specific financial details or event descriptions beyond its filing status.
Why It Matters
This 8-K filing serves as a notification to the SEC and the public about significant corporate events or financial updates for Aldeyra Therapeutics, Inc.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not disclose any new material risks or adverse information.
Key Players & Entities
- Aldeyra Therapeutics, Inc. (company) — Registrant
- July 17, 2025 (date) — Date of earliest event reported
- Lexington, MA (location) — Principal executive offices
- Delaware (location) — State of incorporation
FAQ
What is the exact date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is July 17, 2025.
What is the company's full legal name as specified in its charter?
The company's full legal name is Aldeyra Therapeutics, Inc.
In which state was Aldeyra Therapeutics, Inc. incorporated?
Aldeyra Therapeutics, Inc. was incorporated in Delaware.
What is the address of Aldeyra Therapeutics, Inc.'s principal executive offices?
The address of the principal executive offices is 131 Hartwell Avenue, Suite 320, Lexington, MA 02421.
What is the Standard Industrial Classification (SIC) code for Aldeyra Therapeutics, Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 17, 2025 regarding Aldeyra Therapeutics, Inc. (ALDX).